Sarepta Therapeutics, Inc. SRPT Q1 2025 earnings
Reported May 6, 2025 · After market close
Revenue$744.9MBeat by $5.3M
EPS-$3.42Miss by $3.77
Revenue estimate$739.6M
EPS estimate$0.35
Next report
Aug 5, 2026 (In 6 days)Revenue estimate$366.4M
EPS estimate$0.49
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Sarepta Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Sarepta Therapeutics, Inc. report Q1 2025 earnings?
- Sarepta Therapeutics, Inc. (SRPT) reported Q1 2025 earnings on May 6, 2025 after market close.
- What were Sarepta Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Sarepta Therapeutics, Inc. reported revenue of $744.9M and eps of $-3.42 for Q1 2025.
- Did Sarepta Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $739.6M by $5.3M. EPS missed the consensus estimate of $0.35 by $3.77.
- How did Sarepta Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 80.2% from $413.5M a year earlier.
- Where can I find Sarepta Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-064412) directly on SEC EDGAR. The filing index links above go to sec.gov.